How You Should Be Choosing Your Stocks

From Vantage Point | Ad

Grab your seat at our complimentary LIVE, interactive masterclass for traders. It’s your chance to finally learn how to pick the right stocks and find the best trades.

We’ll also be diving into market forecasting and revealing under-the-radar stocks we believe have significant potential in Q2.

Click here now to join and get access to our forecasting.

STRO Insider Trading (Sutro Biopharma)

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 5.10%

Insider Buying (Last 12 Months): $77,500.00

Insider Selling (Last 12 Months): $72,729.72

Sutro Biopharma Insider Trading History Chart

Sutro Biopharma Share Price & Price History

^$4.60

▼ -0.3 (-6.12%)

As of 05/13/2022 07:55 PM ET

Days: 30 | 90 | 365

Renowned Economist issues startling prediction | America's Future

From Legacy Research | Ad

According to former Goldman Sachs executive, Nomi Prins…

Americans who are hoping for a ‘return to normal’ are going to be shocked when they see what happens next in America.

She says, “If you’re betting your job, savings, or retirement accounts on a return to ‘normal’ you’re about to be left behind by a brand-new crisis few see coming.”

Click here now to see America’s next crisis.

Sutro Biopharma Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/14/2022	William J Newell	CEO	Buy	10,000	$7.75	$77,500.00
9/28/2021	Nicki Vasquez	Insider	Sell	3,906	$18.62	$72,729.72
1/26/2021	Trevor Hallam	Insider	Sell	2,393	$25.71	$61,524.03	58,510
12/28/2020	Trevor Hallam	Insider	Sell	2,393	$22.37	$53,531.41	39,105
11/27/2020	Trevor Hallam	Insider	Sell	2,393	$17.01	$40,704.93	39,105
11/5/2020	Trevor Hallam	Insider	Sell	16,751	$15.00	$251,265.00	53,463
9/28/2020	Trevor Hallam	Insider	Sell	975	$10.26	$10,003.50	27,809
9/18/2020	John Gordon Freund	Director	Sell	400,000	$12.00	$4,800,000.00
9/11/2020	John Gordon Freund	Director	Sell	500,000	$10.00	$5,000,000.00
8/26/2020	Trevor Hallam	Insider	Sell	975	$9.04	$8,814.00	16,790
8/19/2020	John Gordon Freund	Director	Sell	500,000	$8.72	$4,360,000.00
7/27/2020	Trevor Hallam	Insider	Sell	975	$8.06	$7,858.50	17,765
5/26/2020	Trevor Hallam	Insider	Sell	975	$10.00	$9,750.00	19,715
5/14/2020	Arturo Md Molina	Insider	Buy	6,451	$7.75	$49,995.25	12,083
5/14/2020	William J Newell	CEO	Buy	64,516	$7.75	$499,999.00	166,627
4/27/2020	Trevor Hallam	Insider	Sell	975	$9.42	$9,184.50	20,692
3/26/2020	Trevor Hallam	Insider	Sell	975	$9.69	$9,447.75	21,665
2/26/2020	Trevor Hallam	Insider	Sell	975	$10.47	$10,208.25	22,640
1/27/2020	Trevor Hallam	Insider	Sell	975	$10.51	$10,247.25	23,615
11/26/2019	Trevor Hallam	Insider	Sell	975	$10.68	$10,413.00	25,565

Warning: The Last Value Play Gone After August?

From Oxford Club | Ad

In this market...There's ONE STOCK (priced at just under $2) that could be $20 and STILL be a bargain. It brought in more income – including equity sales - in the last 12 months than Disney, Square or Tesla.

But a key announcement in August could send this stock rocketing skyward.

Get the Details Now.

SEC Filings (Institutional Ownership Changes) for Sutro Biopharma (NASDAQ:STRO)

92.68% of Sutro Biopharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Sutro Biopharma Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/13/2022	Northern Trust Corp	391,024	$3.21M	0.0%	-28.3%	0.833%
5/13/2022	Charles Schwab Investment Management Inc.	119,667	$0.98M	0.0%	+9.2%	0.255%
5/13/2022	Lazard Asset Management LLC	6,854	$56K	0.0%	N/A	0.015%
5/13/2022	First Light Asset Management LLC	1,672,497	$13.75M	1.2%	-25.6%	3.564%
5/13/2022	Parkman Healthcare Partners LLC	199,846	$1.64M	0.5%	-9.7%	0.426%
5/13/2022	Tekla Capital Management LLC	163,924	$1.35M	0.0%	-50.0%	0.349%
5/13/2022	Ergoteles LLC	25,738	$0.21M	0.0%	+60.7%	0.055%
5/13/2022	Vanguard Group Inc.	2,230,997	$18.34M	0.0%	+5.3%	4.754%
5/13/2022	Allianz Asset Management GmbH	34,135	$0.28M	0.0%	-33.7%	0.073%
5/13/2022	Dimensional Fund Advisors LP	446,955	$3.67M	0.0%	+23.9%	0.952%
5/12/2022	BlackRock Inc.	3,728,829	$30.65M	0.0%	+0.8%	7.946%
5/12/2022	Panagora Asset Management Inc.	119,064	$0.98M	0.0%	-18.1%	0.254%
5/12/2022	MetLife Investment Management LLC	25,503	$0.21M	0.0%	+55.3%	0.054%
5/12/2022	Acadian Asset Management LLC	238,157	$1.96M	0.0%	+65.7%	0.507%
5/12/2022	Healthcare of Ontario Pension Plan Trust Fund	150,000	$1.23M	0.0%	N/A	0.320%
5/12/2022	Citigroup Inc.	28,671	$0.24M	0.0%	-60.7%	0.061%
5/11/2022	Skandinaviska Enskilda Banken AB publ	5,100	$42K	0.0%	N/A	0.011%
5/11/2022	JPMorgan Chase & Co.	170,766	$1.40M	0.0%	+204.1%	0.364%
5/11/2022	GSA Capital Partners LLP	35,442	$0.29M	0.0%	-50.4%	0.076%
5/10/2022	ProShare Advisors LLC	12,929	$0.11M	0.0%	-19.1%	0.028%
5/9/2022	Principal Financial Group Inc.	26,632	$0.22M	0.0%	-29.5%	0.057%
5/9/2022	Swiss National Bank	76,600	$0.63M	0.0%	+8.2%	0.163%
5/9/2022	Banco Santander S.A.	400,000	$3.29M	0.0%	N/A	0.852%
5/6/2022	IndexIQ Advisors LLC	48,931	$0.40M	0.0%	N/A	0.104%
5/5/2022	Baillie Gifford & Co.	1,868,501	$15.36M	0.0%	+0.7%	3.981%
5/5/2022	Russell Investments Group Ltd.	50,176	$0.41M	0.0%	+188.9%	0.107%
5/4/2022	Prospera Financial Services Inc	6,096	$50K	0.0%	N/A	0.013%
5/4/2022	Victory Capital Management Inc.	35,335	$0.21M	0.0%	-79.7%	0.075%
4/29/2022	Nisa Investment Advisors LLC	26,800	$0.22M	0.0%	N/A	0.058%
4/21/2022	Zurcher Kantonalbank Zurich Cantonalbank	8,740	$72K	0.0%	+251.3%	0.019%
3/3/2022	Walleye Capital LLC	75,412	$1.12M	0.0%	N/A	0.163%
2/23/2022	Barclays PLC	354,387	$5.27M	0.0%	+7.2%	0.766%
2/23/2022	BlackRock Inc.	3,700,043	$55.06M	0.0%	+1.2%	7.997%
2/19/2022	Wells Fargo & Company MN	52,217	$0.78M	0.0%	-53.7%	0.113%
2/16/2022	Allianz Asset Management GmbH	51,511	$0.77M	0.0%	-34.4%	0.111%
2/16/2022	Deutsche Bank AG	57,150	$0.85M	0.0%	+2.5%	0.124%
2/16/2022	Parametric Portfolio Associates LLC	23,208	$0.35M	0.0%	+114.4%	0.050%
2/15/2022	Metropolitan Life Insurance Co NY	9,833	$0.15M	0.0%	-22.6%	0.021%
2/15/2022	Susquehanna International Group LLP	37,758	$0.56M	0.0%	+28.5%	0.082%
2/15/2022	Kennedy Capital Management Inc.	127,925	$1.90M	0.0%	-2.9%	0.276%
2/15/2022	Loomis Sayles & Co. L P	1,115,835	$16.60M	0.0%	-28.9%	2.412%
2/15/2022	Millennium Management LLC	145,635	$2.17M	0.0%	-32.1%	0.315%
2/15/2022	Adage Capital Partners GP L.L.C.	160,000	$2.38M	0.0%	-41.8%	0.346%
2/14/2022	D. E. Shaw & Co. Inc.	30,664	$0.46M	0.0%	-18.0%	0.066%
2/14/2022	Lombard Odier Asset Management Switzerland SA	528,442	$7.86M	0.5%	+9.2%	1.142%
2/14/2022	Citadel Advisors LLC	596,770	$8.88M	0.0%	-10.9%	1.290%
2/14/2022	Squarepoint Ops LLC	37,800	$0.56M	0.0%	+236.7%	0.082%
2/14/2022	Opaleye Management Inc.	680,000	$10.12M	2.1%	+26.4%	1.470%
2/14/2022	Suvretta Capital Management LLC	2,437,795	$36.27M	0.7%	+9.1%	5.269%
2/14/2022	Alliancebernstein L.P.	215,566	$3.21M	0.0%	+5.3%	0.466%
2/14/2022	Credit Suisse AG	28,312	$0.42M	0.0%	+35.2%	0.061%
2/14/2022	State Street Corp	1,590,837	$23.67M	0.0%	-6.6%	3.438%
2/14/2022	DAFNA Capital Management LLC	45,000	$0.67M	0.2%	-47.1%	0.097%
2/14/2022	Goldman Sachs Group Inc.	362,553	$5.40M	0.0%	+11.2%	0.784%
2/14/2022	Nuveen Asset Management LLC	182,200	$2.71M	0.0%	-49.1%	0.394%
2/14/2022	Eventide Asset Management LLC	2,708,975	$40.31M	0.5%	+14.3%	5.855%
2/14/2022	Barclays PLC	354,387	$5.27M	0.0%	+7.2%	0.766%
2/14/2022	GSA Capital Partners LLP	71,412	$1.06M	0.1%	N/A	0.154%
2/14/2022	Invesco Ltd.	166,222	$2.47M	0.0%	-51.9%	0.359%
2/11/2022	Geode Capital Management LLC	743,679	$11.07M	0.0%	+7.5%	1.607%
2/11/2022	Renaissance Technologies LLC	48,700	$0.73M	0.0%	N/A	0.105%
2/11/2022	Charles Schwab Investment Management Inc.	109,549	$1.63M	0.0%	+1.6%	0.237%
2/11/2022	Pentwater Capital Management LP	230,000	$3.42M	0.0%	+9.5%	0.497%
2/11/2022	Allianz Asset Management GmbH	51,511	$0.77M	0.0%	-34.4%	0.111%
2/10/2022	Qube Research & Technologies Ltd	10,092	$0.15M	0.0%	N/A	0.022%
2/10/2022	Rafferty Asset Management LLC	81,129	$1.21M	0.0%	+45.6%	0.175%
2/10/2022	Citigroup Inc.	72,942	$1.09M	0.0%	+71.6%	0.158%
2/10/2022	Acadian Asset Management LLC	143,718	$2.14M	0.0%	-21.2%	0.311%
2/10/2022	Panagora Asset Management Inc.	145,351	$2.16M	0.0%	-5.7%	0.314%
2/10/2022	Connor Clark & Lunn Investment Management Ltd.	21,894	$0.33M	0.0%	-43.0%	0.047%
2/9/2022	Principal Financial Group Inc.	37,769	$0.56M	0.0%	-42.7%	0.082%
2/9/2022	BNP Paribas Arbitrage SA	17,011	$0.25M	0.0%	+61.8%	0.037%
2/9/2022	Dimensional Fund Advisors LP	360,765	$5.37M	0.0%	+43.7%	0.780%
2/8/2022	Frazier Management LLC	1,776,479	$26.43M	2.0%	+21.0%	3.839%
2/8/2022	Bank of America Corp DE	116,430	$1.73M	0.0%	+221.5%	0.252%
2/8/2022	Northern Trust Corp	545,224	$8.11M	0.0%	+1.7%	1.178%
2/7/2022	Victory Capital Management Inc.	173,957	$2.59M	0.0%	+26.9%	0.376%
2/7/2022	SG Americas Securities LLC	12,446	$0.19M	0.0%	-57.3%	0.027%
2/7/2022	Connective Portfolio Management LLC	35,000	$0.53M	0.9%	N/A	0.076%
2/1/2022	Qube Research & Technologies Ltd	10,092	$0.15M	0.0%	N/A	0.022%
1/28/2022	Allspring Global Investments Holdings LLC	34,902	$0.52M	0.0%	N/A	0.075%
1/20/2022	HighMark Wealth Management LLC	4,575	$68K	0.0%	-18.4%	0.010%
1/20/2022	Baillie Gifford & Co.	1,855,250	$27.61M	0.0%	+3.4%	4.010%
12/29/2021	Hudson Bay Capital Management LP	50,000	$0.95M	0.0%	+100.0%	0.108%
11/18/2021	Bank of New York Mellon Corp	166,879	$3.15M	0.0%	+8.6%	0.361%
11/16/2021	Suvretta Capital Management LLC	2,233,695	$42.19M	0.7%	+30.2%	4.828%
11/16/2021	BNP Paribas Arbitrage SA	10,514	$0.20M	0.0%	+133.0%	0.023%
11/16/2021	Janus Henderson Group PLC	216,813	$4.10M	0.0%	+11.3%	0.469%
11/16/2021	Opaleye Management Inc.	537,800	$10.16M	1.9%	+8.2%	1.165%
11/16/2021	Squarepoint Ops LLC	11,228	$0.21M	0.0%	-67.8%	0.024%
11/16/2021	Two Sigma Advisers LP	154,300	$2.92M	0.0%	+67.7%	0.334%
11/16/2021	Two Sigma Investments LP	227,481	$4.30M	0.0%	+11.5%	0.493%
11/16/2021	Verition Fund Management LLC	163,007	$3.08M	0.0%	+56.3%	0.353%
11/16/2021	Metropolitan Life Insurance Co NY	12,710	$0.24M	0.0%	+5.6%	0.028%
11/16/2021	Millennium Management LLC	214,583	$4.05M	0.0%	-55.1%	0.465%
11/16/2021	Citadel Advisors LLC	669,643	$12.65M	0.0%	-13.4%	1.451%
11/15/2021	Point72 Asset Management L.P.	375,000	$7.08M	0.0%	-67.0%	0.813%
11/15/2021	Point72 Hong Kong Ltd	1,329	$25K	0.0%	+99.3%	0.003%
11/15/2021	Cubist Systematic Strategies LLC	5,513	$0.10M	0.0%	-80.7%	0.012%
11/15/2021	California State Teachers Retirement System	49,799	$0.94M	0.0%	-16.7%	0.108%

Data available starting January 2016

Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-drug conjugate (ADC) directed against the cancer target CD74 for patients with multiple myeloma and non-Hodgkin lymphoma that is in Phase 1 clinical trials; and STRO-002, an ADC directed against folate receptor-alpha for patients with ovarian and endometrial cancers, which is in Phase 1 clinical trials. It has collaboration and license agreements with Merck Collaboration to develop research programs focusing on cytokine derivatives for cancer and autoimmune disorders; and Celgene Corporation to discover and develop bispecific antibodies and/or ADCs focused on the field of immuno-oncology. The company was formerly known as Fundamental Applied Biology, Inc. Sutro Biopharma, Inc. was incorporated in 2003 and is headquartered in South San Francisco, California.

Today's Range

Now: $4.60

$4.43

$5.15

50 Day Range

MA: $7.47

$4.60

$9.70

52 Week Range

Now: $4.60

$4.43

$23.70

Volume

1,053,500 shs

Average Volume

571,961 shs

Market Capitalization

$215.90 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.11

Who are the company insiders with the largest holdings of Sutro Biopharma?: Sutro Biopharma's top insider shareholders include:
Trevor Hallam (Insider)
John Gordon Freund (Director)
Nicki Vasquez (Insider)
William J Newell (CEO)
Learn More about top insider investors at Sutro Biopharma.
Who are the major institutional investors of Sutro Biopharma?: Sutro Biopharma's top institutional shareholders include:
BlackRock Inc. — 7.95%
Vanguard Group Inc. — 4.75%
Baillie Gifford & Co. — 3.98%
First Light Asset Management LLC — 3.56%
Dimensional Fund Advisors LP — 0.95%
Banco Santander S.A. — 0.85%
Learn More about top institutional investors of Sutro Biopharma stock.
Which institutional investors are selling Sutro Biopharma stock?: During the previous quarter, STRO stock was sold by these institutional investors:
First Light Asset Management LLC
Tekla Capital Management LLC
Northern Trust Corp
Victory Capital Management Inc.
Citigroup Inc.
GSA Capital Partners LLP
Panagora Asset Management Inc.
Parkman Healthcare Partners LLC
Which institutional investors are buying Sutro Biopharma stock?: Within the last quarter, STRO stock was acquired by institutional investors including:
Banco Santander S.A.
Healthcare of Ontario Pension Plan Trust Fund
JPMorgan Chase & Co.
Vanguard Group Inc.
Acadian Asset Management LLC
Dimensional Fund Advisors LP
IndexIQ Advisors LLC
Russell Investments Group Ltd.